Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 319
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Platinum-based chemotherapy and PARP inhibitors for patients with a germline BRCA pathogenic variant and advanced breast cancer (LATER-BC): retrospective multicentric analysis of post-progression treatments 2023 Guarneri, Valentina + EUROPEAN JOURNAL OF CANCER - -
Radiological response of leptomeningeal metastases according to revised RANO criteria is associated with overall survival in breast cancer patients 2023 Griguolo, GaiaBottosso, MicheleMiglietta, FedericaDieci, Maria VittoriaGuarneri, Valentina + INTERNATIONAL JOURNAL OF CANCER - -
Prognostic impact of extracranial disease control in HER2+ breast cancer-related brain metastases 2023 Bottosso, MicheleGriguolo, GaiaMiglietta, FedericaVernaci, GraziaGuarneri, ValentinaDieci, Maria Vittoria + BRITISH JOURNAL OF CANCER - -
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY 2023 Guarneri, Valentina + BREAST CANCER RESEARCH AND TREATMENT - -
Tucatinib's journey from clinical development to clinical practice: New horizons for HER2-positive metastatic disease and promising prospects for brain metastatic spread 2023 Guarneri, Valentina + CANCER TREATMENT REVIEWS - -
PI3K/PTEN/mTOR pathway dynamic tracking and prognostic value in HR+/HER2- BC patients with residual disease after neoadjuvant chemotherapy: a cohort study 2023 Miglietta, FedericaGriguolo, GaiaBottosso, MicheleDei Tos, Angelo PaoloGuarneri, ValentinaDieci, Maria VittoriaFassan, Matteo + JOURNAL OF CLINICAL PATHOLOGY - -
Epidemiology trends and progress in breast cancer survival: earlier diagnosis, new therapeutics 2023 Guarneri, Valentina + CURRENT OPINION IN ONCOLOGY - -
Fertility Counseling Pattern over Time in Young Patients with Breast Cancer: A Retrospective Analysis at a Large Comprehensive Cancer Center 2023 Barbieri, CMarin, LAndrisani, ASaccardi, CDi Liso, ETozzi, RGuarneri, VDieci, MV + CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY - -
Secondary prevention and treatment innovation of early stage non-small cell lung cancer: Impact on diagnostic-therapeutic pathway from a multidisciplinary perspective 2023 Pasello, GiuliaBonanno, LauraDell'Amore, AndreaTinè, MariaenricaCalabrese, FiorellaMilella, MicheleRea, FedericoGuarneri, Valentina + CANCER TREATMENT REVIEWS - -
Re-Evaluation of Pathologic Complete Response as a Surrogate for Event-Free and Overall Survival in Human Epidermal Growth Factor Receptor 2-Positive, Early Breast Cancer Treated With Neoadjuvant Therapy Including Anti-Human Epidermal Growth Factor Receptor 2 Therapy 2023 Guarneri, Valentina + JOURNAL OF CLINICAL ONCOLOGY - -
Pathologic Complete Response and Individual Patient Prognosis After Neoadjuvant Chemotherapy Plus Anti-Human Epidermal Growth Factor Receptor 2 Therapy of Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer 2023 Guarneri, Valentina + JOURNAL OF CLINICAL ONCOLOGY - -
A phase II study of pembrolizumab plus carboplatin in BRCA-related metastatic breast cancer (PEMBRACA) 2023 Guarneri, V + ESMO OPEN - -
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up† 2023 Guarneri, V. + ANNALS OF ONCOLOGY - -
Serum thymidine kinase activity in patients with HR-positive/HER2-negative advanced breast cancer treated with ribociclib plus letrozole: Results from the prospective BioItaLEE trial 2023 Guarneri, Valentina + EUROPEAN JOURNAL OF CANCER - -
Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review 2023 Miglietta, FDieci, M VConte, P FGuarneri, V + CANCER TREATMENT REVIEWS - -
Type of adjuvant endocrine therapy and disease-free survival in patients with early HR-positive/HER2-positive BC: analysis from the phase III randomized ShortHER trial 2023 Dieci, Maria VittoriaConte, PierfrancoGuarneri, Valentina + NPJ BREAST CANCER - -
Metronomic Temozolomide in Heavily Pretreated Patients With Recurrent Isocitrate Dehydrogenase Wild-type Glioblastoma: A Large Real-Life Mono-Institutional Study 2023 Cerretti, GPadovan, MCaccese, MDenaro, LGuarneri, VLombardi, G + CLINICAL ONCOLOGY - -
A prognostic model based on residual cancer burden and tumor-infiltrating lymphocytes on residual disease after neoadjuvant therapy in HER2+ breast cancer 2023 Miglietta, FedericaGriguolo, GaiaBottosso, MicheleFassan, MatteoGuarneri, ValentinaDieci, Maria Vittoria + CLINICAL CANCER RESEARCH - -
Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy 2023 Miglietta, FedericaDieci, Maria VittoriaGuarneri, Valentina + THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY - -
Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation 2022 Dieci, Maria VittoriaMiglietta, FedericaGiorgi, Carlo AlbertoCumerlato, EnricoAmato, OttaviaMassa, DavideGriguolo, GaiaGenovesi, ElisaFassan, MatteoZarrilli, GiovanniGuarneri, Valentina + BRITISH JOURNAL OF CANCER - -
Mostrati risultati da 21 a 40 di 319
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile